Humans at the Center of Health Care with Shakira Grant, MBBS

In this episode, host Shikha Jain, MD, speaks with Shakira Grant, MBBS, about providing patients and physicians with the proper education on AI tools, focusing on marginalized communities and more. •    Welcome to another exciting episode of Oncology Overdrive 0:14 •    About Grant 0:26 •    The interview 2:07 •    How did you get to where you are today? 2:38 •    Tell me about how you got into the AI space […] What aspects interest you specifically? 4:19 •    Can you take me step-by-step through how CROSS works with different health care organizations? 8:05 •    How does CROSS address concerns about AI?  10:33 •    Do you think AI could widen our disparities if it's taking its prompts from biases in humans? 13:31 •    How do we educate people about fixing the challenges presented by AI so that we can use this data more accurately? 16:38 •    Where do you see this going? […] What would you view as success in the next ten years? 18:22 •    How are you managing the current political climate with this type of work? 21:31 •    What do you plan to do next in your own career? 27:42 •    If someone could only listen to the last few minutes of this episode, what would you want listeners to take away? 29:25 •    How to contact Grant 30:23 •    Thanks for listening 31:28 Shakira J. Grant, MBBS, MSCR, is a physician, entrepreneur, and healthcare executive who works at the intersection of clinical medicine, health policy, and artificial intelligence. She is the founder of CROSS Global Research & Strategy, LLC (CROSS), a company dedicated to providing end-to-end solutions that ease the adoption of AI in healthcare. We'd love to hear from you! Send your comments/questions to Dr. Jain at [email protected]. Follow Healio on X and LinkedIn: @HemOncToday and https://www.linkedin.com/company/hemonctoday/. Follow Dr. Jain on X: @ShikhaJainMD. Grant can be reached on LinkedIn or via email [email protected]. Disclosures: Jain and Grant report no relevant financial disclosures.